Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations

被引:14
|
作者
Stephenson, Kirk A. J. [1 ]
Zhu, Julia [1 ]
Wynne, Niamh [2 ]
Dockery, Adrian [3 ]
Cairns, Rebecca M. [4 ]
Duignan, Emma [2 ]
Whelan, Laura [3 ]
Malone, Conor P. [2 ]
Dempsey, Hilary [2 ]
Collins, Karen [2 ]
Routledge, Shana [1 ]
Pandey, Rajiv [1 ]
Crossan, Elaine [1 ,5 ]
Turner, Jacqueline [1 ]
O'Byrne, James J. [1 ]
Brady, Laura [6 ]
Silvestri, Giuliana [4 ]
Kenna, Paul F. [2 ,3 ]
Farrar, G. Jane [3 ]
Keegan, David J. [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Mater Clin Ophthalm Genet Unit, Dublin, Ireland
[2] Royal Victoria Eye & Ear Hosp, Res Fdn, Dublin, Ireland
[3] Trinity Coll Dublin, Smurfit Inst Genet, Ocular Genet Unit, Dublin, Ireland
[4] Belfast Hlth & Social Care Trust Hosp, Belfast, Antrim, North Ireland
[5] Natl Council Blind Ireland, Whitworth Rd, Dublin 9, Ireland
[6] Fighting Blindness Ireland, Ely Pl, Dublin 2, Ireland
基金
爱尔兰科学基金会;
关键词
Inherited retinal degenerations; Retinal dystrophy; Ocular genetics; Genetic diagnosis; Clinical diagnostic algorithm; Public and patient involvement; DOMINANT RETINITIS-PIGMENTOSA; GENE; PREVALENCE; DYSTROPHY; CARE; UK;
D O I
10.1186/s13023-021-01841-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Inherited retinal degenerations (IRD) are rare genetic disorders with > 300 known genetic loci, manifesting variably progressive visual dysfunction. IRDs were historically underserved due to lack of effective interventions. Many novel therapies will require accurate diagnosis (phenotype and genotype), thus an efficient and effective pathway for assessment and management is required. Methods: Using surveys of existing practice patterns and advice from international experts, an all-Ireland IRD service (Target 5000) was designed. Detailed phenotyping was followed by next generation genetic sequencing in both a research and accredited laboratory. Unresolved pedigrees underwent further studies (whole gene/whole exome/whole genome sequencing). Novel variants were interrogated for pathogenicity (cascade screening, in silico analysis, functional studies). A multidisciplinary team (MDT; ophthalmologists, physicians, geneticists, genetic counsellors) reconciled phenotype with genotype. A bespoke care plan was created for each patient comprising supports, existing interventions, and novel therapies/clinical trials. Results and discussion: Prior to Target 5000, a significant cohort of patients were not engaged with healthcare/support services due to lack of effective interventions. Pathogenic or likely pathogenic variants in IRD-associated genes were detected in 62.3%, with 11.6% having variants of unknown significance. The genotyping arm of Target 5000 allowed a 42.73% cost saving over independent testing, plus the value of MDT expertise/processing. Partial funding has transferred from charitable sources to government resources. Conclusion: Target 5000 demonstrates efficacious and efficient clinical/genetic diagnosis, while discovering novel IRD-implicated genes/variants and investigating mechanisms of disease and avenues of intervention. This model could be used to develop similar IRD programmes in small/medium-sized nations.
引用
下载
收藏
页数:8
相关论文
共 22 条
  • [21] Current management of patients with RPE65 mutation-associated Inherited Retinal Degenerations (RPE65-IRD) in Europe. Results of a 2 years follow-up multinational survey
    Lorenz, Birgit
    Tavares, Joana
    van den Born, L. Ingeborgh
    Marques, Joao Pedro
    Pilotto, Elisabetta
    Stingl, Katarina
    Issa, Peter Charbel
    Leroux, Dorothee
    Dollfus, Helene
    Scholl, Hendrik P. N.
    OPHTHALMIC RESEARCH, 2023, 66 (01) : 727 - 748
  • [22] Current management of patients with RPE65 mutation-associated Inherited Retinal Degenerations (RPE65-IRD) in Europe. Results of a 2-year follow-up multinational survey by the European Vision Institute Clinical Research Network (EVICR.net) and the European Reference Network for Rare Eye Diseases (ERN-EYE)
    Lorenz, Birgit
    Tavares, Joana
    van den Born, Ingeborgh
    Marques, Joao Pedro
    Stingl, Katarina
    Pilotto, Elisabetta
    Issa, Peter Charbel
    Leroux, Dorothee
    Dollfus, Helene
    Scholl, Hendrik P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)